1st injectable antibiotic bone graft substitute gets FDA authorization

Carly Behm -  

Bonesupport's Cerament G, an injectable combination antibiotic bone graft substitute, earned FDA market authorization.

Cerament G is the first injectable of its kind and can be delivered in a single procedure to support bone remodeling and protect bone healing, according to a May 19 news release. It is designed to prevent bone infection that can arise from fractures, orthopedic implants and foot ulcers. 

"This is a significant recognition for the power and promise of our technology, as we are the first-to-market in the U.S. with this breakthrough combination device," Bonesupport CEO Emil Billbaeck said in the release. 

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Learning Opportunities

Featured Webinars

Featured Podcast

Featured Whitepapers